Medication Management

Benefit seen by treating at CD4 counts between 351 and 500/mm3, but challenge is patients are identified too late

Novo Nordisk's Levemir is now indicated for the treatment of type 2 diabetes in combination with oral antidiabetic agents in adults who are not satisfactorily controlled on oral antidiabetic agents alone.

Pharmacy heavyweights from across Canada came together in Toronto on Tuesday, November 4th for the Canadian Association of Chain Drug Stores' Global Innovation in Pharmacy conference.

Bristol-Myers Squibb is introducing Erbitux, a recombinant monoclonal antibody used for colorectal and head/neck cancers.